22 results
Asthma Medications and Mechanism of Action

#Asthma #Medications #Drugs #Pulmonary #Pharmacology #Management #Treatment
#Medications #Drugs ... #Pulmonary #Pharmacology ... #Management #Treatment
IDSA - Doses of Drugs for Treatment of Adults and Children with Multidrug-Resistant Tuberculosis
Step 1 Levofloxacin,
IDSA - Doses of Drugs ... for Treatment of ... #MDRTB #management ... #pharmacology # ... dosing #idsa #drugs
Shock and Vasoactive Drugs 
1) Determine type and etiology of shock
 • Distributive: Sepsis, Anaphylaxis, Neurogenic
Pericardial tamponade, Pulmonary ... pharmacology ... #pharmacology # ... inopressors #diagnosis #management ... #comparison #table
Adjuvant therapies in critical care: steroids to treat infectious diseases
 - Severe Community Acquired Pneumonia
meningitis - Tuberculous ... meningitis - Tuberculous ... ventilation, ARDS acute respiratory ... InfectiousDiseases #Infections #Pharmacology ... #Management #Treatment
Summary table of the mechanism of action, side effect and contraindications of commonly used non-steroidal anti-inflammatory
anti-inflammatory drugs ... #NSAIDS #management ... #pharmacology # ... table #comparison ... #medications #treatment
Causes of Fatigue - Differential Diagnosis Algorithm
Endocrine
 • Hypo/Hyperthyroidism
 • Diabetes
 • Pituitary Insufficiency
 • Adrenal
Causes of Fatigue - Differential ... Endocarditis • Tuberculosis ... Chronic Obstructive Pulmonary ... Myasthenia Gravis Pharmacologic ... Chronic #Fatigue #Differential
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
RIPE Therapy - Drug ... Microbiologically Confirmed Pulmonary ... Tuberculosis - ... #medications #pharmacology ... IDSA #Guidelines #Treatment
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
Individualized Treatment ... Resistant Tuberculosis ... #MDRTB #management ... #Treatment #antimicrobials ... #regimens #pharmacology
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
inhibitors • Injection drug ... Treatment: Active ... Initiating Treatment ... TB #Diagnosis #Management ... #Treatment #ActiveTB
Approach to Eosinophilic Lung Diseases
 • Acute Eosinophilic Pneumonia (< 1 wk) - ~30yo, M; Recent
Syndrome (> 6 mo) - Respiratory ... Fever, wheezing • Drug ... Lung #Diseases #pulmonary ... #differential # ... diagnosis #comparison